• December 14, 2005  

    The chief executive of the American Red Cross resigned amid criticism of the charity’s disaster relief efforts, including its response to Hurricane Katrina. After a background report, a public service professor discusses the problems facing the Red Cross. Continue reading

  • December 13, 2005  

    An ambitious national pilot project called the “Cancer Genome Atlas” will attempt to map the genetic mutations present in different types of cancer. Two experts discuss the project. Continue reading

  • December 13, 2005  

    Medicare’s prescription drug benefit program is set to begin in less than three weeks. An expert discusses the multitude of available options for seniors. Continue reading

  • December 12, 2005  

    An update on the first federal trial against Merck and Co. over its painkiller Vioxx, which ended in a mistrial Monday. Continue reading

  • December 12, 2005  

    In an attempt to crack down on the production of the highly-addictive and destructive drug methamphetamine, officials in Oregon tightened access to medicines containing pseudoephedrine, an ingredient found in many common medicines and a main component used to make the drug. Continue reading

  • December 1, 2005  

    Some scientists have discovered a set of “anti-aging” genes in animals that — when manipulated — have similar life-extending effects as calorie-restrictive diets. Correspondent Tom Bearden reports on the research into the relationship between genes and aging. Continue reading

  • December 1, 2005  

    A World Health Organization initiative to provide anti-retroviral drugs to people with AIDS in low-income countries fell short of its goal of three million people by 2005. Two experts discuss the effectiveness of the initiative and the challenges of fighting the AIDS epidemic. Continue reading

  • November 28, 2005   BY  

    In an effort to recover from major financial losses sustained by controversy over its bestselling painkiller Vioxx, drugmaker Merck & Co. announced it would cut 7,000 jobs over the next three years and close five of its manufacturing plants. Continue reading

  • November 28, 2005  

    A report on the plight of those living without health insurance. Continue reading

  • November 25, 2005  

    An update on the ethics troubles of a key scientist in the field of embryonic stem cell research. Continue reading